Piotr Garstecki
Amministratore Delegato presso SCOPE FLUIDICS S.A.
Profilo
Piotr Garstecki is the founder of Scope Fluidics SA and Curiosity Diagnostics Sp zoo, which were founded in 2010 and 2012 respectively.
At Scope Fluidics SA, he held the title of Chairman-Management Board, and at Curiosity Diagnostics Sp zoo, he held the title of Member-Management Board.
Dr. Garstecki earned a doctorate degree from the Polish Academy of Sciences in 2002.
Posizioni attive di Piotr Garstecki
Società | Posizione | Inizio |
---|---|---|
SCOPE FLUIDICS S.A. | Amministratore Delegato | - |
Curiosity Diagnostics Sp Zoo
Curiosity Diagnostics Sp Zoo Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Curiosity Diagnostics Sp zoo is a Polish company that develops technology solutions for medical diagnostic and healthcare markets. The company is based in Warsaw, Poland. The company was founded by Szymon Ruta, Marcin Izydorzak, Piotr Garstecki. Marcin Izydorzak has been the CEO since incorporation. Curiosity Diagnostics was acquired by Bio-Rad Laboratories, Inc. from Scope Fluidics SA on August 03, 2022 for $36.98 million. | Fondatore | 01/01/2012 |
Formazione di Piotr Garstecki
Polish Academy of Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SCOPE FLUIDICS S.A. | Health Technology |
Aziende private | 1 |
---|---|
Curiosity Diagnostics Sp Zoo
Curiosity Diagnostics Sp Zoo Miscellaneous Commercial ServicesCommercial Services Part of Bio-Rad Laboratories, Inc., Curiosity Diagnostics Sp zoo is a Polish company that develops technology solutions for medical diagnostic and healthcare markets. The company is based in Warsaw, Poland. The company was founded by Szymon Ruta, Marcin Izydorzak, Piotr Garstecki. Marcin Izydorzak has been the CEO since incorporation. Curiosity Diagnostics was acquired by Bio-Rad Laboratories, Inc. from Scope Fluidics SA on August 03, 2022 for $36.98 million. | Commercial Services |
- Borsa valori
- Insiders
- Piotr Garstecki